Antimicrobial Stewardship in the Covid-19 Pandemic
- PMID: 35898252
- PMCID: PMC9310298
- DOI: 10.1177/00185787221075190
Antimicrobial Stewardship in the Covid-19 Pandemic
Abstract
During COVID-19 pandemic, implementing and maintaining an antimicrobial stewardship protocol obtained both low rates of MDR microorganisms and low antimicrobial use in an 800-bed hospital network in northern Italy. Infectious diseases specialist consulting was crucial to maintain this protocol active.
Keywords: anti-infectives; infection control; infectious diseases.
© The Author(s) 2022.
Conflict of interest statement
Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
References
-
- Chibabhai V, Duse AG, PErovic O, Richards GA. Collateral damage of the COVID-19 pandemic: exacerbation of antimicrobial resistance and disruptions to antimicrobial stewardship programmes? S Afr Med J. 2020;110(7):572-573. - PubMed
-
- Barrasa-Villar J, Aibar-Remo C, Prieto-Andre P, et al.. Impact on morbidity, mortality, and length of stay of hospital-acquired infections by resistant microorganisms. Clin Infect Dis. 2017;65:644-652. - PubMed
-
- Sun Jin L, Fisher J. MDRO transmission in acute hospitals during the COVID-19 pandemic. Curr Opin Infect Dis. 2021;34:365-371. - PubMed
LinkOut - more resources
Full Text Sources